Peripherin-mediated death of motor neurons rescued by overexpression of neurofilament NF-H proteins

Journal of Neurochemistry

Volumn 85, Issue 1, 2003, Pages 248-256

  Beaulieu, Jean Martin ^b   Julien, Jean Pierre ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis; Cyclin dependant kinase 5; Intermediate filament; Neurofilaments; Peripherin; Transgenic

Indexed keywords

NEUROFILAMENT H PROTEIN; NEUROFILAMENT PROTEIN; PERIPHERIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXOPLASM; CELL INCLUSION; DISEASE MODEL; GENE OVEREXPRESSION; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOICHIOMETRY; TRANSGENE; VENTRAL ROOT;

ANIMALIA; MUS MUSCULUS;

EID: 0037381242     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01653.x     Document Type: Article

References (41)

1. Athlan E. S. and Mushynski W. E. (1997) Heterodimeric associations between neuronal intermediate filament proteins. J. Biol. Chem. 272, 31073-31078.
2. Beaulieu J. M., Nguyen M. D. and Julien J. P. (1999a) Late onset death of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol. 147, 531-544.
3. Beaulieu J. M., Robertson J. and Julien J. P. (1999b) Interactions between peripherin and neurofilaments in cultured cells, disruption of peripherin assembly by the NF-M and NF-H subunits. Biochem. Cell Biol. 77, 41-45.
4. Beaulieu J. M., Jacomy H. and Julien J. P. (2000) Formation of intermediate filament protein aggreates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit. J. Neurosci. 20, 5321-5328.
5. Bergeron C., Beric-Maskarel K., Muntasser S., Weyer L., Somerville M. J. and Percy M. E. (1994) Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neuropathol. Exp. Neurol. 53, 221-230.
6. Bömmel H., Xie G., Rossoll W., Wiese S., Jablonka S., Boehm T. and Sendtner M. (2002) Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motor neuron disease. J. Cell Biol. 159, 563-569.
7. Carpenter S. (1968) Proximal axonal enlargement in motor neuron disease. Neurology 18, 841-851.
8. Ching G. Y. and Liem R. K. H. (1993) Assembly of type IV neuronal intermediate filaments in non neuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol. 122, 1323-3335.
9. Cleveland D. W. (1999) From Charcot to SODI, mechanisms of selective motor neuron death in ALS. Neuron 24, 515-520.
10. Corbo M. and Hays A. P. (1992) Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J. Neuropathol. Exp. Neurol. 51, 531-537.
11. Côté F., Collard J. F. and Julien J. P. (1993) Progressive neuropathy in transgenic mce expressing the human neurofilament heavy gene, a mouse model of amyotrophic lateral sclerosis. Cell 73, 35-46.
12. Couillard-Després J. S., Zhu Q., Wong P. C., Price D. L., Cleveland D. W. and Julien J. P. (1998) Protective effect of neurofilament NF-H overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl Acad. Sci. USA 95, 9626-9630.
13. Hirokawa N. (1997) The mechanisms of fast and slow transport in neurons: identification and characterization of the new kinesin superfamily motors. Curr. Opin. Neurobiol. 7, 605-614.
14. Hoffman P. N. and Lasek R. J. (1975) The slow component of axonal transport. J. Cell Biol. 642, 316-322.
15. Houseweart M. K. and Cleveland D. W. (1999) Bcl-2 overexpression does not protect neurons from mutant neurofilament-mediated motor neuron degeneration. J. Neurosci. 19, 6446-6456.
16. Julien J. P. (2001) Amyotrophic lateral sclerosis: unfolding toxicity misfolded. Cell 104, 581-591.
17. Julien J. P. and Beaulieu J. M. (2000) Cytosqueletal abnormalities in amyotrophic lateral sclerosis, beneficial or detrimental effects? J. Neurol. Sci. 180, 7-14.
18. Kriz J., Zhu Q., Julien J. P. and Padjen A. L. (2000) Electrophysiological properties of axons in mice lacking neurofilament subunit genes: disparity between conduction velocity and axon diameter in absence of NF-H. Brain Res. 885, 32-44.
19. Lee M. K., Xu Z., Wong P. C. and Cleveland D. W. (1993) Neurofilaments are obligate heteropolymers in vivo. J. Cell. Biol. 122, 1337-1350.
20. Lee M. K., Marszalek J. R. and Cleveland D. W. (1994) A mutant neurofilament subunit causes massive, selective motor neuron death, implications for the pathogenesis of human motor neuron disease. Neuron 13, 975-988.
21. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M. and Tsai L. H. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364.
22. Marszalek J. R., Williamson T. L., Lee M. K., Xu Z., Hoffman P. N., Becher M. W., Crawford T. O. and Cleveland D. W. (1996) Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport. J. Cell Biol. 135, 711-724.
23. Martin N., Jaubert J., Gounon P., Salido E., Haase G., Szatanik M. and Guénet J.-L. (2002) A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat. Genet. 32, 443-447.
24. Migheli A., Pezzulo T., Attanasio A. and Schiffer D. (1993) Peripherin immunoreactive structures in amyotrophic lateral sclerosis. Lab. Inves. 68, 185-191.
25. Nguyen M. D., Larivière R. C. and Julien J. P. (2001) Deregulation of cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30, 135-147.
26. Patrick G. N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P. and Tsai L. H. (1999) Conversion of p35 to p25 deregulates cdk5 activity and promotes neurodegeneration. Nature 402, 615-621.
27. Portier M. M., Croizat B. and Gros F. (1982) A sequence of changes in cytoskeletal components during neuroblastoma differentiation. FEBS Lett. 146, 283-288.
28. Robertson J., Beaulieu J. M., Doroudchi M. M., Durham H. D., Julien J. P. and Mushynski W. E. (2001) Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. J. Cell Biol. 155, 217-226.
29. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Halperin J. J., Herzfeldt B., Van den Bergh R., Hung W. Y., Bird T., Deng G., Mulder D. W., Smyth C., Laing N. G., Soriano E., Percak-Vance M. A., Haines J., Rouleau G. A., Gusella J. S., Horvitz H. R., Brown R. H., Jr, Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K., Valentine J. S. and Bredesen D. E. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
30. Roy S., Coffee P., Smith G., Liem R. K., Brady S. T. and Black M. M. (2000) Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport. J. Neurosci. 20, 6849-6861.
31. Sasaki S. and Iwata M. (1996) Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology 47, 535-540.
32. Terada S., Nakata T., Peterson A. C. and Hirokawa N. (1996) Visualization of slow axonal transport in vivo. Science 273, 784-788.
33. Thompson M. A. and Ziff E. B. (1989) Structure of the gene encoding peripherin, an NGF-regulated neuronal-specific type III intermediate filament protein. Neuron 2, 1043-1053.
34. Troy C. M., Muma N. A., Greene L. A., Price D. L. and Shelanski M. L. (1990) Regulation of peripherin and neurofilament expression in regenerating rat motor neurons. Brain Res. 529, 232-238.
35. Wang L., Ho C. L., Sun D., Liem R. K. and Brown A. (2000) Rapid movement of axonal neurofilaments interrupted by prolonged pauses. Nat. Cell Biol. 2, 137-141.
36. Williamson T. L. and Cleveland D. W. (1999) Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2, 50-56.
37. Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W. and Price D. L. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116.
38. Wong N. K., He B. P. and Strong M. J. (2000) Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 59, 972-982.
39. Zhang B., Tu P. H., Abtahian F., Trojanowski J. Q. and Lee V. M. Y. (1997) Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 139, 1307-1315.
40. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H. W., Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y. and Hirokawa N. (2001) Charcot-Marie-Tooth disease type 2A causes by mutation in a microtubule motor KIF1Bβ. Cell 105, 587-597.
41. Zhu Q., Couillard-Després J. S. and Julien J. P. (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148, 299-316.